ÂÜÀòÂÒÂ×

Catherine Friedman has served as a member of our board of directors since August 2018. Ms. Friedman is an independent financial consultant who has been serving public and private companies in the life sciences industry since 2006. Previously, Ms. Friedman held numerous executive positions during a 23-year investment banking career with Morgan Stanley & Co., an investment bank, including Managing Director, and Head of West Coast Healthcare, and co-head of the Biotechnology Practice. Ms. Friedman is the Chair of the board of directors for GRAIL, Inc., and also serves as a member of the boards of Altaba Inc. (formerly Yahoo! Inc.), Radius Health, Inc., Seer, Inc., Vividion Therapeutics, Inc. and Revolution Healthcare Acquisition Corp. Ms. Friedman is a trustee of The Darden School Foundation at the University of Virginia. Ms. Friedman holds a B.A. in economics from Harvard University and an MBA from The University of Virginia’s Darden School of Business.